Trial intelligence / Profile preview

Betadine Vaginal Cleansing Before Cesarean Section

NCT07715409Not yet recruiting

Sponsor
Mohamed Mousa Mohamed Mousa
Start
May 2027
Primary completion
May 2027
Countries
1
01

Overview

Randomised trial of povidone-iodine in surgical site infection (SSI) and endometritis (2 arms), sponsored by Mohamed Mousa Mohamed Mousa. Primary endpoint: Incidence of postoperative wound-related complications at 8 weeks. Planned start May 2027; status: not yet recruiting.

02

Drugs

povidone-iodine
03

Conditions

surgical site infection (SSI)endometritis

Beyond the preview

Go deeper on NCT07715409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07715409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call